Prolor Biotech and long acting hgh

cvictorg · Oct 1, 2009

PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH) formerly Modigene Inc., today announced the initiation of a Phase I clinical trial of its long-acting human growth hormone drug candidate hGH-CTP.

hGH-CTP is being developed to provide growth hormone deficient adults and children with the option to replace the multiple injections per week that are currently required with a once-weekly or bi-monthly injection. The initiation of the trial follows a successful safety and immunogenicity study of hGH-CTP in primates and regulatory approvals by the IRB committee of the Tel-Aviv Medical Center and the Israeli Ministry of Health.

PROLOR's CTP technology is based on an amino acid sequence that occurs naturally in humans, the carboxyl terminal peptide. When attached to a therapeutic protein, CTP extends the time that the protein is active in the body.

**broken link removed**

jm425 · Oct 1, 2009

Thanks for posting that article up bro. Very interesting and informative.

xxsuprman22xx · Oct 1, 2009

Very cool. thanks for sharing.

morepain · Oct 1, 2009

nutropin used to have a version that was a once per month shot, kit came with a giant ass 16 gauge needle, it created somewhat of a bolus under the skin (very thick solution). years ago there was a guy that handled nothing but pharmacy nutropin depot and nutropin aq...have no idea what happened to him

disgraziato · Oct 2, 2009

Well, if theyre starting a phase I clinical study on this hgh, we should have it available underground by now!!!lol...I'm very interested in this idea...never really hear anything about the peg-hgh thats been floating around for years....It would be great if they nailed it this time, where actual gh levels remain elevated continually or if it just increases your pulses over an extended period or both, and over how long....HINT HINT Labs.....